A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.

3/13/2026, 10:56 AM

Summary of Bill S 4066

This bill, designated as S. 4066 in the 119th Congress and introduced on March 11, 2026, aims to declare that the approved application for the drug mifepristone under the Federal Food, Drug, and Cosmetic Act for ending intrauterine pregnancies is considered withdrawn. Additionally, it seeks to create a Federal tort claim for harm caused to women by chemical abortion drugs along with other related purposes.

Current Status of Bill S 4066

Bill S 4066 is currently in the status of Bill Introduced since March 11, 2026. Bill S 4066 was introduced during Congress 119 and was introduced to the Senate on March 11, 2026. Bill S 4066's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of March 11, 2026

Bipartisan Support of Bill S 4066

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 4066

Primary Policy Focus

Alternate Title(s) of Bill S 4066

A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.